AG-270 is an experimental drug which acts as an inhibitor of the methionine adenosyltransferase 2α (MAT2A) enzyme, which is important for the development of some types of cancer. AG-270 has reached early stage human clinical trials.
References
Wikipedia
AG-270
Tags
- 2-Pyridyl compounds
- 4-Methoxyphenyl compounds
- Cycloalkenes
- Experimental drugs
- Phenyl compounds
- Pyrazolopyrimidines